Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Allergan Plc (AGN)

Allergan Plc (AGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 63,503,972
  • Shares Outstanding, K 329,002
  • Annual Sales, $ 16,089 M
  • Annual Income, $ -5,271 M
  • 60-Month Beta 1.20
  • Price/Sales 3.95
  • Price/Cash Flow 5.26
  • Price/Book 1.09
Trade AGN with:
  • Price/Earnings ttm 10.94
  • Earnings Per Share ttm 17.64
  • Most Recent Earnings 5.22 on 02/10/20
  • Next Earnings Date 05/07/20
  • Annual Dividend & Yield 2.96 (0.00%)
  • Most Recent Dividend 0.740 on 04/15/20
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 4.24
  • Number of Estimates 1
  • High Estimate 4.24
  • Low Estimate 4.24
  • Prior Year 3.79
  • Growth Rate Est. (year over year) +11.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
181.21 +6.52%
on 04/09/20
196.45 -1.75%
on 05/06/20
+11.94 (+6.59%)
since 04/08/20
3-Month
158.67 +21.65%
on 03/18/20
202.21 -4.55%
on 02/12/20
-4.03 (-2.05%)
since 02/07/20
52-Week
114.27 +68.92%
on 06/17/19
202.21 -4.55%
on 02/12/20
+52.97 (+37.82%)
since 05/08/19

Most Recent Stories

More News
Aegon NV: Q3 Earnings Snapshot

Aegon NV: Q3 Earnings Snapshot

AGN : 193.02 (+0.02%)
AEG : 4.94 (+0.20%)
Judge: Walgreens contributed to San Francisco opioid crisis

SAN FRANCISCO (AP) — A federal judge ruled Wednesday that Walgreens can be held responsible for contributing to San Francisco's opioid crisis for over-dispensing highly addictive drugs for years without...

AGN : 193.02 (+0.02%)
States reach deal over marketing, safety of generic opioids

HARRISBURG, Pa. (AP) — A former opioid manufacturer has agreed in principle to pay up to $2.4 billion in a deal with a dozen states over its marketing and product safety practices, state attorneys general...

MCK : 386.91 (+1.89%)
CAH : 80.91 (+2.08%)
AGN : 193.02 (+0.02%)
JNJ : 178.87 (+0.07%)
WVa opioid trial verdict still pending nearly a year later

CHARLESTON, W.Va. (AP) — Last July, a federal judge in West Virginia in the first lawsuit to go to trial over the U.S. opioid addiction epidemic.

MCK : 386.91 (+1.89%)
CAH : 80.91 (+2.08%)
AGN : 193.02 (+0.02%)
Tentative $161.5M settlement reached in WVa opioid trial

CHARLESTON, W.Va. (AP) — Attorneys for the state of West Virginia and two remaining pharmaceutical manufacturers have reached a tentative $161.5 million settlement just as closing arguments were set...

MCK : 386.91 (+1.89%)
CAH : 80.91 (+2.08%)
JNJ : 178.87 (+0.07%)
AGN : 193.02 (+0.02%)
Walgreens, Florida settle opioid costs lawsuit for $683M

ST. PETERSBURG, Fla. (AP) — The Walgreens pharmacy chain has reached a $683 million settlement with the state of Florida in a lawsuit accusing the company of improperly dispensing millions of painkillers...

AGN : 193.02 (+0.02%)
CAH : 80.91 (+2.08%)
1 drug company settles ahead of San Francisco opioid trial

SAN FRANCISCO (AP) — Drugmaker Endo Pharmaceuticals has agreed to pay the city of San Francisco $10 million over its role in selling prescription opioids in the city.

AGN : 193.02 (+0.02%)
J&J's Janssen settles with WVa for $99M in opioid lawsuit

CHARLESTON, W.Va. (AP) — West Virginia will receive $99 million in a settlement finalized Monday with Johnson & Johnson's subsidiary Janssen Pharmaceuticals Inc. over in the state that has long led...

$SPX : 4,064.67 (-0.29%)
$DOWI : 34,368.19 (-0.08%)
$IUXX : 11,969.34 (-0.60%)
CAH : 80.91 (+2.08%)
AGN : 193.02 (+0.02%)
JNJ : 178.87 (+0.07%)
EXPLAINER: Where do US opioid trials, settlements stand?

The effort to hold drug companies, pharmacies and distributors accountable for their role in the opioid crisis has led to a whirlwind of legal activity around the U.S. that can be difficult keep tabs on....

AGN : 193.02 (+0.02%)
CAH : 80.91 (+2.08%)
JNJ : 178.87 (+0.07%)
Carnival, Change Healthcare rise; Block, Acuity fall

NEW YORK (AP) —

BAX : 53.13 (+1.43%)
AGN : 193.02 (+0.02%)
CME : 176.96 (-0.53%)
AYI : 188.93 (+0.11%)
UNH : 536.07 (-0.16%)
CHNG : 27.49 (+0.26%)
CCL : 9.99 (+0.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 194.42
1st Resistance Point 193.72
Last Price 193.02
1st Support Level 191.98
2nd Support Level 190.94
3rd Support Level N/A

See More

52-Week High 202.21
Last Price 193.02
Fibonacci 61.8% 168.62
Fibonacci 50% 158.24
Fibonacci 38.2% 147.86
52-Week Low 114.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar